CST: 30/09/2016 04:59:24   

MyDx Announces a Webcast (February 4, 2016) for a Shareholder Update and Q&A

244 Days ago

SAN DIEGO, CA --(Marketwired - January 29, 2016) - MyDx, Inc. (OTCQB: MYDX), creator of MyDx (My Diagnostic), the first handheld chemical analyzer for consumers, will host a webcast on Thursday, February 4, 2016 at 1:00 p.m. Pacific time (4:00 p.m. Eastern time) to provide a business update and offer a Q&A for Shareholders and interested parties.

Shareholders and other interested parties can register for the webcast:

http://cdxlife.equisolvewebcast.com/update-2-4-16

Shareholders and other interested parties can participate in the webcast by dialing 866-373-3407 (U.S. and Canada) or 412-902-1037 (international) at least 15 minutes before the call is scheduled to begin, where they will be assisted by a live operator to connect to the webcast.

A replay of the conference call will be available beginning two hours after its completion through February 11, 2016, by dialing 877-660-6853 (U.S. and Canada) or 201-612-7415 (international) and entering Conference ID 13629710.

An archived webcast will be available on the Company's website at http://ir.cdxlife.com/.

About MyDx, Inc.

MyDx, Inc. (OTCQB: MYDX) is a science and technology company based in San Diego, California whose mission is to empower people to live a healthier life by revealing the purity of what they eat, drink and inhale in the palm of their hands and in real time. The Company has developed MyDx, an affordable portable analyzer that provides real-time chemical analysis and fits in the palm of your hands. MyDx leverages over a decade of established electronic nose technology to measure chemicals of interest and has four sensors being developed in its lab that will be compatible with the MyDx Analyzer and App. For more information, please visit www.cdxlife.com.

Forward-Looking Statements:

This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov.

For additional information about the company, visit www.cdxlife.com.

Company Contact:
Jotti Dhillon
MyDx, Inc.
800-814-4550
jotti@cdxlife.com